Lexington, KY, United States of America

Ragotham Reddy Pinninti

This inventor holds 1 USPTO granted patent. Top assignee: University of Kentucky Research Foundation. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ragotham Reddy Pinninti. Retrieved from https://idiyas.com/inventor/ragotham-reddy-pinninti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Ragotham Reddy Pinninti

Introduction

Ragotham Reddy Pinninti is an accomplished inventor based in Lexington, KY (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent that enhances the delivery of active drugs.

Latest Patents

Ragotham Reddy Pinninti holds a patent for "Compounds including Cox inhibitor moiety and enhanced delivery of active drugs using same." This patent includes compounds that feature a cyclooxygenase enzyme inhibitor moiety and a moiety derived from a drug of interest. In some embodiments, the drug of interest is an opioid. The compounds allow for enhanced delivery rates across the skin, which can significantly improve therapeutic outcomes.

Career Highlights

Ragotham is associated with the University of Kentucky Research Foundation, where he conducts research and develops innovative solutions in drug delivery. His work is pivotal in advancing the understanding and application of drug compounds.

Collaborations

He collaborates with notable colleagues such as Priyanka Ghosh and Audra Lynn Stinchcomb, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ragotham Reddy Pinninti's work exemplifies the intersection of innovation and practical application in the pharmaceutical field. His contributions are paving the way for enhanced drug delivery systems that can benefit many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…